APOC3 抗体 (FITC)
Quick Overview for APOC3 抗体 (FITC) (ABIN7454059)
抗原
See all APOC3 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Goat anti-Human Apo CIII [F09] Antibody FITC Conjugated
-
免疫原
- Human Apolipoprotein CIII
-
亚型
- IgG
-
-
anti-Apolipoprotein C-III (APOC3) (AA 1-99) antibody
APOC3 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein C-III (APOC3) antibodyAPOC3 适用: 人 WB, IHC, IF 宿主: 兔 Monoclonal unconjugated
anti-Apolipoprotein C-III (APOC3) antibodyAPOC3 适用: 人, 大鼠, 小鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein C-III (APOC3) (AA 21-99) antibodyAPOC3 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein C-III (APOC3) (AA 21-99) antibodyAPOC3 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 8H7 unconjugated
anti-Apolipoprotein C-III (APOC3) (AA 41-80) antibodyAPOC3 适用: 大鼠, 小鼠 WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein C-III (APOC3) (AA 21-99) antibodyAPOC3 适用: 人 WB, ELISA, ICC, IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein C-III (APOC3) (AA 21-99) antibodyAPOC3 适用: 小鼠 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein C-III (APOC3) antibodyAPOC3 适用: 人 ELISA, IHC 宿主: 兔 Monoclonal 8H12 unconjugated Recombinant Antibody
anti-Apolipoprotein C-III (APOC3) (AA 70-99), (C-Term) antibodyAPOC3 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB15169 unconjugated
-
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12 months
-
-
- APOC3 (Apolipoprotein C-III (APOC3))
-
别名
- ApoCIII
-
背景
- Background: Apo CIII contains 79 amino acid residues. The m.w. is 8.7 kDa (Brewer et al., 1974). It may inhibit the activation of lipoprotein lipase by apo CIII. Apo CIII is a constituent of both apoB- and apoAI-containing lipoproteins in the circulation. Apo CIII plays a pivotal role in regulating the plasma metabolism of VLDL, IDL, and LDL, primarily by inhibiting receptor-mediated uptake of these lipoproteins by the liver. (Sehayek and Eisenberg 1991, Aalto-Setala et al., 1992, Zheng et al., 2007)
-
基因ID
- 345
-
NCBI登录号
- NP_000031
-
UniProt
- P02656
-
途径
- Carbohydrate Homeostasis, Lipid Metabolism
抗原
-
